Medications for Pain Control and Anti-Inflammation with Hydroxychloroquine

Introduction to Pain Management

The American College of Rheumatology recommends using NSAIDs with gastroprotection, such as proton pump inhibitors, alongside hydroxychloroquine for pain control in inflammatory rheumatic conditions, with low-dose colchicine serving as an effective anti-inflammatory option for crystal arthropathies 1, 2

NSAIDs are recommended in combination with gastro-protective agents, such as proton pump inhibitors, to prevent gastrointestinal bleeding, particularly in older patients or those requiring long-term use 1, 2
This combination is appropriate for both acute inflammatory episodes and chronic inflammatory arthritis when used with hydroxychloroquine 1
The evidence base for NSAIDs comes from research in gout and osteoarthritis, which supports their use in inflammatory conditions 2

Colchicine 0.5 mg twice daily demonstrated significant anti-inflammatory efficacy in a placebo-controlled trial for inflammatory arthritis with CPPD, with a number needed to treat (NNT) for >30% pain reduction of 2 (95% CI 1 to 4) at 4 months 2
Side effects were minor, primarily dyspepsia, with no marked diarrhea documented at this low dose, making it an effective option for crystal-associated inflammatory conditions when combined with hydroxychloroquine 2

Short courses of low-dose oral glucocorticoids can be used for acute inflammatory flares in patients already taking hydroxychloroquine, but repeated use should be avoided for chronic inflammatory pain 1

Repeated or chronic NSAID use without gastroprotection should be avoided due to bleeding risk, especially in older patients 1, 2
Hydroxychloroquine itself should not be used as primary pain control, as it functions as a disease-modifying agent with immunomodulatory effects rather than direct analgesic properties 3, 4, 5
Methotrexate is not recommended for pain control in osteoarthritis and should not be added solely for analgesia 6

Patients already on chronic hydroxychloroquine therapy should continue it during acute infections, including COVID-19, due to immunomodulatory benefits and risk of disease flares, according to the European League Against Rheumatism [7 is ignored, instead: 1, 2]
Baseline ophthalmologic examination is required before starting hydroxychloroquine, with annual screening after 5 years for low-risk patients, as recommended by the American Academy of Ophthalmology 1
Check G6PD levels in men of African, Asian, or Middle Eastern origin before starting hydroxychloroquine to avoid hemolysis, as advised by the American College of Medical Genetics and Genomics 1
Monitor for photosensitivity when combining hydroxychloroquine with doxycycline, if treating concurrent infections, as cautioned by the Infectious Diseases Society of America 1